SCHEMBL15915433

SCHEMBL15915433

CCN(CC)C(=O)CSc1ccccc1Br

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.69
ALDH1A1 P00352 6/20 0.55
HPGD P15428 3/20 0.48
RECQL P46063 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HTR7 P34969 1/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
ALOX5AP P20292 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184557 0.78 HTR7 (0.46) HSD17B10ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL6299141 0.78 HTR7 (0.46) HSD17B10ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL8705447 0.78 HTR7 (0.49) HSD17B10ALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL18301097 0.77 ALDH1A1 (0.55) HSD17B10ALDH1A1HPGDKDM4ELMNA
SCHEMBL30421706 0.75 CYP1A2 (0.61) HSD17B10ALDH1A1HPGDRAB9AHTR7
SCHEMBL1703413 0.75 CYP1A2 (0.61) HSD17B10ALDH1A1HPGDRAB9AHTR7
SCHEMBL30421739 0.74 HTR7 (0.44) HSD17B10ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL15916105 0.74 SMN1; SMN2 (0.52) HSD17B10ALDH1A1SMN1; SMN2RAB9AHTR7
SCHEMBL5083791 0.71 CYP1A2 (0.49) HSD17B10ALDH1A1HPGDNPC1RAB9A
SCHEMBL23149012 0.71 HTR7 (0.42) HSD17B10ALDH1A1HPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495359-A1 FLAP MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 EP disclosed
EP-3070085-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 EP disclosed
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 EP disclosed
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 US disclosed
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 US disclosed
EP-3070085-A1 FLAP MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-09-21 EP disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 US disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 US disclosed
US-9079866-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
US-20140221311-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R HSD17B10 673/4885ALDH1A1 200/4885HPGD 119/4885
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R HSD17B10 528/4885ALDH1A1 427/4885HPGD 97/4885
US-20140221311-A1 FLAP MODULATORS PGF, FEN1, TBXA2R HSD17B10 528/4885ALDH1A1 427/4885HPGD 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.